Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer and HIV Vaccines Enter the Therapeutic Era

2.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

3.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

4.

Firefighters who eat better can combat cancer.

5.

Prostate cancer therapies: AI-based image analysis detects early organ damage


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot